Evolus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. 

CEO
David Moatazedi
CEODavid Moatazedi
Employees
332
Employees332
Headquarters
Newport Beach, California
HeadquartersNewport Beach, California
Founded
2012
Founded2012
Employees
332
Employees332

EOLS Key Statistics

Market cap
362.02M
Market cap362.02M
Price-Earnings ratio
-6.13
Price-Earnings ratio-6.13
Dividend yield
Dividend yield
Average volume
1.62M
Average volume1.62M
High today
$6.13
High today$6.13
Low today
$4.30
Low today$4.30
Open price
$5.35
Open price$5.35
Volume
10.54M
Volume10.54M
52 Week high
$14.60
52 Week high$14.60
52 Week low
$4.09
52 Week low$4.09

Stock Snapshot

Evolus(EOLS) stock is priced at $5.59, giving the company a market capitalization of 362.02M. It carries a P/E multiple of -6.13.

On 2026-03-04, Evolus(EOLS) stock traded between a low of $4.30 and a high of $6.13. Shares are currently priced at $5.59, which is +30.0% above the low and -8.8% below the high.

The Evolus(EOLS)'s current trading volume is 10.54M, compared to an average daily volume of 1.62M.

During the past year, Evolus(EOLS) stock moved between $4.09 at its lowest and $14.60 at its peak.

During the past year, Evolus(EOLS) stock moved between $4.09 at its lowest and $14.60 at its peak.

EOLS News

Nasdaq 1d
Evolus Q4 2025 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Evolus Q4 2025 Earnings Call Transcript
TipRanks 1d
Evolus Secures New Credit Facility and Reports Profitability

An announcement from Evolus ( (EOLS) ) is now available. On March 3, 2026, Evolus secured a new senior secured asset-based revolving credit facility of up to $...

TipRanks 1d
Evolus reports Q4 EPS 0c, consensus 4c

Reports Q4 revevnuee $90.3M, consensus $89.58M. “In 2025 we generated nearly $300 million in total net revenue delivering our sixth consecutive year of double-d...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.